HOME >> MEDICINE >> NEWS
Hormone therapy offers new hope for ovarian cancer patients

Researchers at the University of Edinburgh have shown that hormone therapy can extend life in ovarian cancer patients, giving women a new alternative to chemotherapy.

The study, published today in Clinical Cancer Research, has proved for the first time that the targeted use of an anti-oestrogen drug could prolong the life of some patients by up to three years, and delay the use of chemotherapy in others.

Letrozole hormone therapy already used with great success in the treatment of breast tumours - attacks cancer by turning off its oestrogen supply. But scientists now believe that in those ovarian cancers which are highly sensitive to oestrogen, this blocking mechanism could slow the growth and spread of disease.

The study was funded by Cancer Research UK and involved 44 women with high oestrogen receptor (ER) levels, whose cancer had relapsed after surgery and chemotherapy.

Scientists used a blood-borne tumour marker, CA-125, to track the progress of tumours during hormone treatment. They discovered that one quarter of the women showed no tumour growth after six months of anti-oestrogen therapy, and 33 per cent of the group with the greatest ER values showed a positive response which delayed the use of chemotherapy.

John F. Smyth, Professor of Medical Oncology at the University of Edinburgh, led the research programme.

He said: This is an important landmark in the research and treatment of ovarian cancer. Despite intense scientific research over the past 20 years, there have been few new leads in our understanding of how this disease operates. But this study suggests that the addition of hormone therapy to our treatment strategy could extend and improve the lives of women with cancer.

Ovarian cancer is the most commonly fatal of gynaecological cancers, affecting 1 in 48 women. Nearly 7,000 new cases are diagnosed in the UK each year.

Current treatment involves surgery and chemoth
'"/>

Contact: Anna Smyth
anna.smyth@ed.ac.uk
44-131-651-4400
University of Edinburgh
14-Jun-2007


Page: 1 2

Related medicine news :

1. Hormone regulates fondness for food
2. Hormone drug type makes survival difference in advanced breast cancer
3. Hormone replacement therapy may improve trip down memory lane
4. Hormone-replacement therapy hurts hearing, study finds
5. Hormones could be prescription for living longer
6. Hormone found to decrease appetite and increase activity
7. Hormone therapy may prevent heart attacks for women in their 50s
8. Hormone use linked to increased breast cancer risk among black women
9. Hormone can predict pulmonary hypertension and potential death or survival
10. Hormone linked to good hearing as we age
11. Hormone aldosterone is promising target for stroke treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/8/2020)... ... January 08, 2020 , ... ... in Living Magazine’s 2019 Best of Memorial Readers’ Choice Awards. Located ... skincare. Being named Best MedSpa in Memorial reflects Mirror Mirror Beauty Boutique’s commitment ...
(Date:1/7/2020)... COLLEGE STATION, Texas (PRWEB) , ... January 07, ... ... cleanroom solutions, today unveiled another facility expansion, adding to the company’s 200,000 sq. ... consists of 25,000 sq. ft. of manufacturing space dedicated to POD architectural, mechanical, ...
(Date:1/7/2020)... IRVINE, Calif. (PRWEB) , ... January 07, 2020 , ... ... CBD products can be created while keeping the focus on the individual customer service ... is putting their customers first and the profits second. By taking care of the ...
(Date:1/7/2020)... ... 06, 2020 , ... MemoryCare.com , a comprehensive resource ... Memory Care Facilities in Lakeland, Florida. The guide identifies 6 memory care communities ... to the Alzheimer’s Association , 5.6 million people age 65 and older ...
(Date:1/7/2020)... PETERSBURG, Fla. (PRWEB) , ... January 07, 2020 , ... ... has made an award for ?Orphan Drug Designation? for its THC and CBD proprietary ... MMJ-002 is one of MMJ’s lead drugs and the company is confident that it ...
Breaking Medicine News(10 mins):
(Date:1/12/2020)... , ... January 10, 2020 ... ... that Founder and CEO Remo Moomiaie-Qajar, MD has been selected to present ... company that has developed a vast platform with its proprietary Cargocyte™ next ...
(Date:1/12/2020)... ... 2020 , ... New Life Hiking Spa offers 5 reasons why ... to book an affordable option. , Improved health and happiness: , Although a ... life, sight see and a try a new cuisine, the joy that people experience ...
(Date:1/10/2020)... FRANCISCO (PRWEB) , ... January 10, 2020 , ... ... collaborative AI-powered diagnostics tools for radiology and the healthcare industry — today announced ... brings over 20 years of industry experience, working with health systems in sales ...
Breaking Medicine Technology:
Cached News: